Abstract
We model the propagation of an infection, in a population, as a simplified age-dependent branching process. We analytically estimate the fraction of population, needed to be infected or immuned, to achieve herd immunity for an infection. We calculate this estimation as a function of the incubation period of the contagion, contact probability among the infected and susceptible population, and the probability of disease transmission from an infected to a susceptible individual. We show how herd immunity is strongly dependent on the incubation period, and it may be extremely difficult to achieve herd immunity in case of large incubation period. We derive the distribution of generation time from basic principles, which, by far, has been assumed in an ad hoc manner in epidemiological studies. We quantify the success probability of quarantine measures before achieving herd immunity, and discuss a novel method for designing effective quarantine measures in the absence of any pharmaceutical interventions. We also compare the effectiveness of an early imposition against a delayed imposition of lockdown, of the same duration, in mitigating infection from a population.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The manuscript only uses mathematical models and no data.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The manuscript uses no data files.
